|
AbCellera Biologics Inc.
|
-0.51 USD
|
-61074.51%
|
|
Alkermes plc
|
2.14 USD
|
14678.972%
|
|
Agenus Inc.
|
-13.75 USD
|
-2169.018%
|
|
Aptorum Group Limited
|
-0.62 USD
|
-50220.968%
|
|
Ardelyx, Inc.
|
-0.30 USD
|
-103896.667%
|
|
Dyadic International, Inc.
|
-0.24 USD
|
-129895.833%
|
|
Eton Pharmaceuticals, Inc.
|
-0.04 USD
|
-854667.123%
|
|
Lantern Pharma Inc.
|
-1.47 USD
|
-21123.81%
|
|
Inhibikase Therapeutics, Inc.
|
-3.57 USD
|
-8639.216%
|
|
Novavax, Inc.
|
-5.41 USD
|
-5666.913%
|
|
Janux Therapeutics, Inc.
|
-1.32 USD
|
-23535.606%
|
|
Pyxis Oncology, Inc.
|
-1.85 USD
|
-16764.324%
|
|
TransCode Therapeutics, Inc.
|
-103.61 USD
|
-201.12%
|
|
Ocuphire Pharma, Inc.
|
-0.46 USD
|
-67723.913%
|
|
Outlook Therapeutics, Inc.
|
-4.72 USD
|
-6509.958%
|
|
Madrigal Pharmaceuticals, Inc.
|
-19.99 USD
|
-1460.73%
|
|
Reviva Pharmaceuticals Holdings, Inc.
|
-1.25 USD
|
-24859.2%
|
|
SELLAS Life Sciences Group, Inc.
|
-1.34 USD
|
-23182.836%
|
|
Syros Pharmaceuticals, Inc.
|
-5.81 USD
|
-5269.88%
|
|
Barinthus Biotherapeutics plc
|
-1.91 USD
|
-16234.555%
|
|
Windtree Therapeutics, Inc.
|
-92.23 USD
|
-238.274%
|
|
Xeris Biopharma Holdings, Inc.
|
-0.45 USD
|
-69231.111%
|
|
Clearside Biomedical, Inc.
|
-0.53 USD
|
-58766.038%
|
|
C4 Therapeutics, Inc.
|
-2.67 USD
|
-11585.019%
|
|
Alnylam Pharmaceuticals, Inc.
|
-3.52 USD
|
-8763.352%
|
|
AlloVir, Inc.
|
-1.83 USD
|
-16948.634%
|
|
Arrowhead Pharmaceuticals, Inc.
|
-1.91 USD
|
-16234.555%
|
|
VYNE Therapeutics Inc.
|
-2.77 USD
|
-11163.177%
|
|
Bicycle Therapeutics plc
|
-5.08 USD
|
-6041.535%
|
|
BioXcel Therapeutics, Inc.
|
-6.15 USD
|
-4973.008%
|
|
ChromaDex Corporation
|
-0.07 USD
|
-473329.439%
|
|
Chimerix, Inc.
|
-0.93 USD
|
-33447.312%
|
|
Corbus Pharmaceuticals Holdings, Inc.
|
-10.31 USD
|
-2926.091%
|
|
Caribou Biosciences, Inc.
|
-1.38 USD
|
-22507.971%
|
|
CRISPR Therapeutics AG
|
-1.94 USD
|
-15981.959%
|
|
Precision BioSciences, Inc.
|
-15.96 USD
|
-1854.825%
|
|
Fate Therapeutics, Inc.
|
-1.64 USD
|
-18923.78%
|
|
Fortress Biotech, Inc.
|
-8.47 USD
|
-3583.471%
|
|
Fortress Biotech, Inc.
|
-8.47 USD
|
-3583.471%
|
|
HOOKIPA Pharma Inc.
|
-8.63 USD
|
-3515.18%
|
|
ImmuCell Corporation
|
-0.75 USD
|
-41498.667%
|
|
IDEAYA Biosciences, Inc.
|
-1.96 USD
|
-15817.857%
|
|
Immix Biopharma, Inc.
|
-0.89 USD
|
-34955.056%
|
|
Incyte Corporation
|
2.67 USD
|
11785.019%
|
|
Innoviva, Inc.
|
2.92 USD
|
10784.589%
|
|
IO Biotech, Inc.
|
-1.98 USD
|
-15657.071%
|
|
Jaguar Health, Inc.
|
-107.42 USD
|
-190.439%
|
|
Keros Therapeutics, Inc.
|
-5.20 USD
|
-5899.808%
|
|
Ligand Pharmaceuticals Incorporated
|
3.02 USD
|
10430.795%
|
|
ContextLogic Inc.
|
-13.36 USD
|
-2235.254%
|
|
MiMedx Group, Inc.
|
0.48 USD
|
65097.917%
|
|
MEI Pharma, Inc.
|
2.67 USD
|
11785.019%
|
|
NextCure, Inc.
|
-2.25 USD
|
-13766.222%
|
|
Onconetix, Inc.
|
-2.19 USD
|
-14146.119%
|
|
Oncternal Therapeutics, Inc.
|
-13.43 USD
|
-2223.083%
|
|
Opthea Limited
|
-0.35 USD
|
-89040.0%
|
|
Psyence Biomedical Ltd.
|
-7.85 USD
|
-3874.395%
|
|
Vaxcyte, Inc.
|
-4.14 USD
|
-7435.99%
|
|
PDS Biotechnology Corporation
|
-1.39 USD
|
-22345.324%
|
|
Precigen, Inc.
|
-0.39 USD
|
-79897.436%
|
|
Pharming Group N.V.
|
-0.16 USD
|
-194893.75%
|
|
Phathom Pharmaceuticals, Inc.
|
-3.93 USD
|
-7838.677%
|
|
Pieris Pharmaceuticals, Inc.
|
-21.80 USD
|
-1331.147%
|
|
PureTech Health plc
|
-2.38 USD
|
-13008.824%
|
|
Rigel Pharmaceuticals, Inc.
|
-1.44 USD
|
-21565.972%
|
|
Avidity Biosciences, Inc.
|
-2.91 USD
|
-10621.306%
|
|
Reviva Pharmaceuticals Holdings, Inc.
|
-1.25 USD
|
-24859.2%
|
|
Sangamo Therapeutics, Inc.
|
-1.48 USD
|
-20980.405%
|
|
Sol-Gel Technologies Ltd.
|
-1.01 USD
|
-30790.099%
|
|
Acelyrin, Inc.
|
-5.43 USD
|
-5645.672%
|
|
Salarius Pharmaceuticals, Inc.
|
-0.00 USD
|
-8210163.158%
|
|
Summit Therapeutics Inc.
|
-0.99 USD
|
-31414.141%
|
|
Sensei Biotherapeutics, Inc.
|
-1.22 USD
|
-25472.951%
|
|
Senti Biosciences, Inc.
|
-16.01 USD
|
-1848.72%
|
|
Stoke Therapeutics, Inc.
|
-2.38 USD
|
-13008.824%
|
|
Elevation Oncology, Inc.
|
-1.34 USD
|
-23182.836%
|
|
Alaunos Therapeutics, Inc.
|
-21.97 USD
|
-1320.073%
|
|
Telomir Pharmaceuticals, Inc. Common Stock
|
-0.44 USD
|
-70806.818%
|
|
Entrada Therapeutics, Inc.
|
-0.20 USD
|
-155895.0%
|
|
VistaGen Therapeutics, Inc.
|
-1.52 USD
|
-20425.658%
|
|
Kintara Therapeutics, Inc.
|
-3.23 USD
|
-9559.133%
|
|
Wave Life Sciences Ltd.
|
-0.54 USD
|
-57675.926%
|
|
Seer, Inc.
|
-1.35 USD
|
-23010.37%
|
|
Verrica Pharmaceuticals Inc.
|
-1.48 USD
|
-20980.405%
|
|
Aadi Bioscience, Inc.
|
-2.44 USD
|
-12686.475%
|
|
ESSA Pharma Inc.
|
-0.60 USD
|
-51898.333%
|
|
GlycoMimetics, Inc.
|
-0.58 USD
|
-53691.379%
|
|
GT Biopharma, Inc.
|
-5.64 USD
|
-5431.738%
|
|
Inhibrx Biosciences, Inc.
|
-5.12 USD
|
-5993.555%
|
|
Akebia Therapeutics, Inc.
|
-0.28 USD
|
-111325.0%
|
|
Catalyst Pharmaceuticals, Inc.
|
0.67 USD
|
46665.672%
|
|
Longboard Pharmaceuticals, Inc.
|
-2.39 USD
|
-12953.975%
|
|
Orchestra BioMed Holdings, Inc.
|
-1.48 USD
|
-20980.405%
|
|
Alzamend Neuro, Inc.
|
-14.72 USD
|
-2019.497%
|
|
Sorrento Therapeutics, Inc.
|
-1.37 USD
|
-22672.993%
|
|
TRACON Pharmaceuticals, Inc.
|
-2.20 USD
|
-14081.364%
|
|
Viracta Therapeutics, Inc.
|
-1.32 USD
|
-23535.606%
|
|
Rocket Pharmaceuticals, Inc.
|
-2.92 USD
|
-10584.589%
|
|
Aptose Biosciences Inc.
|
-7.58 USD
|
-4015.963%
|
|
ZyVersa Therapeutics, Inc.
|
-1089.67 USD
|
71.368%
|
|
Soligenix, Inc.
|
-12.66 USD
|
-2364.376%
|
|
Century Therapeutics, Inc.
|
-2.30 USD
|
-13464.783%
|
|
Kura Oncology, Inc.
|
-2.08 USD
|
-14899.519%
|
|
TScan Therapeutics, Inc.
|
-1.36 USD
|
-22840.441%
|
|
Intensity Therapeutics, Inc.
|
-1.38 USD
|
-22507.971%
|
|
Ocean Biomedical, Inc.
|
-0.03 USD
|
-1186173.764%
|
|
CytomX Therapeutics, Inc.
|
-0.01 USD
|
-4051718.182%
|
|
Autolus Therapeutics plc
|
-1.20 USD
|
-25899.167%
|
|
Mineralys Therapeutics, Inc.
|
-1.99 USD
|
-15577.889%
|
|
EyePoint Pharmaceuticals, Inc.
|
-1.82 USD
|
-17042.308%
|
|
Eterna Therapeutics Inc.
|
-4.08 USD
|
-7546.814%
|
|
Adaptive Biotechnologies Corporation
|
-1.56 USD
|
-19899.359%
|
|
GRI Bio, Inc.
|
-28.25 USD
|
-1004.389%
|
|
Xenetic Biosciences, Inc.
|
-2.71 USD
|
-11412.546%
|
|
Tenaya Therapeutics, Inc.
|
-1.68 USD
|
-18470.833%
|
|
IGM Biosciences, Inc.
|
-4.71 USD
|
-6523.992%
|
|
INmune Bio, Inc.
|
-1.67 USD
|
-18582.036%
|
|
Heron Therapeutics, Inc.
|
-0.80 USD
|
-38898.75%
|
|
SAB Biotherapeutics, Inc.
|
-7.64 USD
|
-3983.639%
|
|
Pasithea Therapeutics Corp.
|
-12.65 USD
|
-2366.324%
|
|
Entero Therapeutics, Inc.
|
-47.88 USD
|
-551.608%
|
|
Milestone Pharmaceuticals Inc.
|
-1.39 USD
|
-22345.324%
|
|
X4 Pharmaceuticals, Inc.
|
-0.57 USD
|
-54635.088%
|
|
Atara Biotherapeutics, Inc.
|
-65.18 USD
|
-378.659%
|
|
Coherus BioSciences, Inc.
|
-2.53 USD
|
-12231.621%
|
|
Verastem, Inc.
|
-3.96 USD
|
-7778.535%
|
|
Abeona Therapeutics Inc.
|
-2.53 USD
|
-12231.621%
|
|
Pliant Therapeutics, Inc.
|
-2.75 USD
|
-11245.091%
|
|
Tonix Pharmaceuticals Holding Corp.
|
-219.09 USD
|
-42.403%
|
|
Histogen Inc.
|
-3.46 USD
|
-8917.052%
|
|
Aprea Therapeutics, Inc.
|
-3.95 USD
|
-7798.481%
|
|
Surrozen, Inc.
|
-21.33 USD
|
-1362.682%
|
|
Organovo Holdings, Inc.
|
-1.60 USD
|
-19399.375%
|
|
Lixte Biotechnology Holdings, Inc.
|
-2.66 USD
|
-11628.947%
|
|
Ovid Therapeutics Inc.
|
-0.74 USD
|
-42060.811%
|
|
Panbela Therapeutics, Inc.
|
-232.42 Thousand USD
|
99.866%
|
|
CASI Pharmaceuticals, Inc.
|
-2.02 USD
|
-15345.05%
|
|
Cadrenal Therapeutics, Inc. Common Stock
|
-0.62 USD
|
-50220.968%
|
|
Centessa Pharmaceuticals plc
|
-1.57 USD
|
-19771.975%
|
|
Hepion Pharmaceuticals, Inc.
|
-12.32 USD
|
-2432.386%
|
|
Arcturus Therapeutics Holdings Inc.
|
-1.12 USD
|
-27756.25%
|
|
BioRestorative Therapies, Inc.
|
-2.47 USD
|
-12531.174%
|
|
Apollomics, Inc.
|
-2.32 USD
|
-13347.845%
|
|
Amarin Corporation plc
|
-0.15 USD
|
-207893.333%
|
|
Mesoblast Limited
|
-0.89 USD
|
-34955.056%
|
|
Turnstone Biologics Corp.
|
-4.77 USD
|
-6440.671%
|
|
Kymera Therapeutics, Inc.
|
-2.52 USD
|
-12280.556%
|
|
Synaptogenix, Inc.
|
-29.56 USD
|
-955.447%
|
|
Tiziana Life Sciences Ltd
|
-0.16 USD
|
-194893.75%
|
|
Aurinia Pharmaceuticals Inc.
|
-0.54 USD
|
-57675.926%
|
|
BriaCell Therapeutics Corp.
|
-0.29 USD
|
-107482.759%
|
|
Monopar Therapeutics Inc.
|
-0.58 USD
|
-53691.379%
|
|
Exelixis, Inc.
|
0.65 USD
|
48098.462%
|
|
Better Therapeutics, Inc.
|
-1.69 USD
|
-18360.947%
|
|
Nurix Therapeutics, Inc.
|
-2.65 USD
|
-11673.208%
|
|
Apellis Pharmaceuticals, Inc.
|
-4.45 USD
|
-6911.011%
|
|
NLS Pharmaceutics AG
|
-0.32 USD
|
-97396.875%
|
|
Dermata Therapeutics, Inc.
|
-40.18 USD
|
-676.481%
|
|
Aridis Pharmaceuticals, Inc.
|
-1.64 USD
|
-18923.78%
|
|
Gritstone bio, Inc.
|
-1.20 USD
|
-25899.167%
|
|
Jasper Therapeutics, Inc.
|
-6.18 USD
|
-4948.382%
|
|
TNF Pharmaceuticals, Inc.
|
-5.33 USD
|
-5753.471%
|
|
Avid Bioservices, Inc.
|
-2.23 USD
|
-13890.583%
|
|
Insmed Incorporated
|
-5.34 USD
|
-5742.509%
|
|
Virpax Pharmaceuticals, Inc.
|
-12.97 USD
|
-2305.474%
|
|
MediWound Ltd.
|
-0.75 USD
|
-41498.667%
|
|
OmniAb, Inc.
|
-0.51 USD
|
-61074.51%
|
|
Alector, Inc.
|
-1.56 USD
|
-19899.359%
|
|
Seres Therapeutics, Inc.
|
-0.89 USD
|
-34955.056%
|
|
Checkpoint Therapeutics, Inc.
|
-2.77 USD
|
-11163.177%
|
|
Zai Lab Limited
|
-3.46 USD
|
-8917.052%
|
|
Revance Therapeutics, Inc.
|
-3.83 USD
|
-8045.953%
|
|
Aura Biosciences, Inc.
|
-1.93 USD
|
-16065.285%
|
|
Lyell Immunopharma, Inc.
|
-0.93 USD
|
-33447.312%
|
|
Immunic, Inc.
|
-2.11 USD
|
-14686.256%
|
|
Tarsus Pharmaceuticals, Inc.
|
-4.62 USD
|
-6653.03%
|
|
Veracyte, Inc.
|
-1.02 USD
|
-30487.255%
|
|
InMed Pharmaceuticals Inc.
|
-1.01 USD
|
-30790.099%
|
|
FibroGen, Inc.
|
-2.92 USD
|
-10584.589%
|
|
SeaStar Medical Holding Corporation
|
-30.29 USD
|
-930.01%
|
|
Adial Pharmaceuticals, Inc.
|
-5.44 USD
|
-5635.11%
|
|
Sonnet BioTherapeutics Holdings, Inc.
|
-18.14 USD
|
-1619.901%
|
|
Jazz Pharmaceuticals plc
|
6.95 USD
|
4589.065%
|
|
Cyclacel Pharmaceuticals, Inc.
|
-26.75 USD
|
-1066.318%
|
|
Amylyx Pharmaceuticals, Inc.
|
0.73 USD
|
42838.356%
|
|
TG Therapeutics, Inc.
|
0.09 USD
|
349472.9%
|
|
Galecto, Inc.
|
-36.08 USD
|
-764.717%
|
|
Calithera Biosciences, Inc.
|
-7.94 USD
|
-3829.345%
|
|
Fortrea Holdings Inc.
|
-0.04 USD
|
-814495.3%
|
|
KalVista Pharmaceuticals, Inc.
|
-3.44 USD
|
-8969.477%
|
|
Aptevo Therapeutics Inc.
|
-62.62 USD
|
-398.227%
|
|
XBiotech Inc.
|
-0.81 USD
|
-38417.284%
|
|
Jasper Therapeutics, Inc.
|
-6.18 USD
|
-4948.382%
|
|
Lyra Therapeutics, Inc.
|
-1.26 USD
|
-24661.111%
|
|
Foghorn Therapeutics Inc.
|
-2.34 USD
|
-13232.906%
|
|
Y-mAbs Therapeutics, Inc.
|
-0.49 USD
|
-63571.429%
|
|
Theravance Biopharma, Inc.
|
-1.00 USD
|
-31099.0%
|
|
Ultragenyx Pharmaceutical Inc.
|
-8.25 USD
|
-3681.697%
|
|
Metagenomi, Inc. Common Stock
|
-1.82 USD
|
-17042.308%
|
|
Vaxxinity, Inc.
|
-0.45 USD
|
-69231.111%
|
|
BioCryst Pharmaceuticals, Inc.
|
-1.18 USD
|
-26339.831%
|
|
Gain Therapeutics, Inc.
|
-1.71 USD
|
-18145.029%
|
|
Cartesian Therapeutics, Inc.
|
-42.49 USD
|
-634.267%
|
|
NexImmune, Inc.
|
-30.82 USD
|
-912.297%
|
|
Creative Medical Technology Holdings, Inc.
|
-3.76 USD
|
-8197.606%
|
|
Marker Therapeutics, Inc.
|
-1.93 USD
|
-16065.285%
|
|
Regeneron Pharmaceuticals, Inc.
|
37.05 USD
|
942.078%
|
|
Chemomab Therapeutics Ltd.
|
-2.06 USD
|
-15045.146%
|
|
Scopus BioPharma Inc.
|
-0.55 USD
|
-56625.455%
|
|
RAPT Therapeutics, Inc.
|
-3.05 USD
|
-10129.18%
|
|
Ainos, Inc.
|
-3.36 USD
|
-9185.417%
|
|
Pluri Inc.
|
-3.99 USD
|
-7719.298%
|
|
Prothena Corporation plc
|
-2.76 USD
|
-11203.986%
|
|
Adaptimmune Therapeutics plc
|
-0.57 USD
|
-54635.088%
|
|
Celularity Inc.
|
-11.02 USD
|
-2731.125%
|
|
Rallybio Corporation
|
-1.84 USD
|
-16855.978%
|
|
Cue Biopharma, Inc.
|
-1.11 USD
|
-28007.207%
|
|
MeiraGTx Holdings plc
|
-1.49 USD
|
-20838.926%
|
|
Omeros Corporation
|
-1.88 USD
|
-16495.213%
|
|
Humacyte, Inc.
|
-1.07 USD
|
-29057.944%
|
|
Immunocore Holdings plc
|
-1.13 USD
|
-27509.735%
|
|
Cocrystal Pharma, Inc.
|
-1.86 USD
|
-16673.656%
|
|
Cidara Therapeutics, Inc.
|
-5.25 USD
|
-5842.667%
|
|
Blueprint Medicines Corporation
|
-8.37 USD
|
-3627.479%
|
|
CalciMedica, Inc.
|
-7.65 USD
|
-3978.301%
|
|
Cabaletta Bio, Inc.
|
-1.65 USD
|
-18808.485%
|
|
Marinus Pharmaceuticals, Inc.
|
-2.63 USD
|
-11762.738%
|
|
Scholar Rock Holding Corporation
|
-1.99 USD
|
-15577.889%
|
|
Sana Biotechnology, Inc.
|
-1.46 USD
|
-21269.178%
|
|
Pulmatrix, Inc.
|
-3.87 USD
|
-7961.757%
|
|
Elicio Therapeutics, Inc.
|
-6.96 USD
|
-4382.615%
|
|
Vigil Neuroscience, Inc.
|
-2.13 USD
|
-14547.418%
|
|
Intellia Therapeutics, Inc.
|
-5.42 USD
|
-5656.273%
|
|
Adlai Nortye Ltd. American Depositary Shares
|
-7.26 USD
|
-4197.383%
|
|
Cytokinetics, Incorporated
|
-5.45 USD
|
-5624.587%
|
|
Eloxx Pharmaceuticals, Inc.
|
-16.65 USD
|
-1773.814%
|
|
Nutriband Inc.
|
-0.69 USD
|
-45115.942%
|
|
Protara Therapeutics, Inc.
|
-3.57 USD
|
-8639.216%
|
|
Vor Biopharma Inc.
|
-1.75 USD
|
-17728.0%
|
|
Roivant Sciences Ltd.
|
5.55 USD
|
5721.441%
|
|
Evogene Ltd.
|
-5.23 USD
|
-5865.392%
|
|
ProKidney Corp.
|
-0.57 USD
|
-54635.088%
|
|
Applied Therapeutics, Inc.
|
-1.42 USD
|
-21871.127%
|
|
Hoth Therapeutics, Inc.
|
-2.30 USD
|
-13464.783%
|
|
BridgeBio Pharma, Inc.
|
-3.95 USD
|
-7798.481%
|
|
CorMedix Inc.
|
-0.91 USD
|
-34184.615%
|
|
BioLineRx Ltd.
|
-0.94 USD
|
-33090.426%
|
|
Tango Therapeutics, Inc.
|
-1.08 USD
|
-28787.963%
|
|
Galectin Therapeutics Inc.
|
-0.74 USD
|
-42060.811%
|
|
Atai Life Sciences N.V.
|
-0.25 USD
|
-124696.0%
|
|
Renovaro Biosciences Inc.
|
-0.84 USD
|
-37041.667%
|
|
Aerovate Therapeutics, Inc.
|
-2.87 USD
|
-10770.732%
|
|
Zentalis Pharmaceuticals, Inc.
|
-4.47 USD
|
-6879.642%
|
|
Sagimet Biosciences Inc.
|
-2.66 USD
|
-11628.947%
|
|
MediciNova, Inc.
|
-0.17 USD
|
-183423.529%
|
|
Praxis Precision Medicines, Inc.
|
-18.69 USD
|
-1569.288%
|
|
Cardio Diagnostics Holdings, Inc.
|
-0.66 USD
|
-47171.212%
|
|
GeoVax Labs, Inc.
|
-10.22 USD
|
-2952.74%
|
|
Axsome Therapeutics, Inc.
|
-5.27 USD
|
-5820.114%
|
|
Biomea Fusion, Inc.
|
-3.44 USD
|
-8969.477%
|
|
PTC Therapeutics, Inc.
|
-8.37 USD
|
-3627.479%
|
|
Mereo BioPharma Group plc
|
-0.04 USD
|
-697864.206%
|
|
Cullinan Oncology, Inc.
|
-3.69 USD
|
-8355.014%
|
|
Syndax Pharmaceuticals, Inc.
|
-2.98 USD
|
-10369.463%
|
|
Absci Corporation
|
-1.20 USD
|
-25899.167%
|
|
NRx Pharmaceuticals, Inc.
|
-3.98 USD
|
-7738.945%
|
|
4D Molecular Therapeutics, Inc.
|
-2.58 USD
|
-11992.636%
|
|
Dyne Therapeutics, Inc.
|
-3.95 USD
|
-7798.481%
|
|
Kiniksa Pharmaceuticals, Ltd.
|
0.20 USD
|
156095.0%
|
|
Ventyx Biosciences, Inc.
|
-3.30 USD
|
-9354.242%
|
|
Allakos Inc.
|
-2.14 USD
|
-14478.972%
|
|
Imunon, Inc.
|
-2.16 USD
|
-14343.981%
|
|
Fulcrum Therapeutics, Inc.
|
-1.59 USD
|
-19522.013%
|
|
Corcept Therapeutics Incorporated
|
1.02 USD
|
30687.255%
|
|
BioAtla, Inc.
|
-2.58 USD
|
-11992.636%
|
|
NLS Pharmaceutics AG
|
-0.32 USD
|
-97396.875%
|
|
Bio-Path Holdings, Inc.
|
-33.64 USD
|
-827.438%
|
|
Allogene Therapeutics, Inc.
|
-2.09 USD
|
-14827.751%
|
|
Larimar Therapeutics, Inc.
|
-0.84 USD
|
-37041.667%
|
|
XOMA Corporation
|
-4.04 USD
|
-7622.525%
|
|
Kezar Life Sciences, Inc.
|
-1.40 USD
|
-22185.0%
|
|
Cara Therapeutics, Inc.
|
-2.19 USD
|
-14146.119%
|
|
aTyr Pharma, Inc.
|
-0.94 USD
|
-33090.426%
|
|
Aligos Therapeutics, Inc.
|
-3.52 USD
|
-8763.352%
|
|
Akero Therapeutics, Inc.
|
-2.89 USD
|
-10695.502%
|
|
Viridian Therapeutics, Inc.
|
-5.31 USD
|
-5775.518%
|
|
Eliem Therapeutics, Inc.
|
-1.30 USD
|
-23899.231%
|
|
EyeGate Pharmaceuticals, Inc.
|
-2.54 USD
|
-12183.071%
|
|
Akari Therapeutics, Plc
|
-2.04 USD
|
-15193.627%
|
|
Tevogen Bio Holdings Inc.
|
-0.00 USD
|
-77997400.0%
|
|
Halozyme Therapeutics, Inc.
|
2.13 USD
|
14747.418%
|
|
Lexaria Bioscience Corp.
|
-1.01 USD
|
-30790.099%
|
|
UroGen Pharma Ltd.
|
-3.55 USD
|
-8688.451%
|
|
Sutro Biopharma, Inc.
|
-1.78 USD
|
-17427.528%
|
|
ZIVO Bioscience, Inc.
|
-4.60 USD
|
-6682.391%
|
|
Orgenesis Inc.
|
-1.91 USD
|
-16234.555%
|
|
Entera Bio Ltd.
|
-0.31 USD
|
-100541.935%
|
|
GH Research PLC
|
-0.68 USD
|
-45780.882%
|
|
Lisata Therapeutics, Inc.
|
-2.58 USD
|
-11992.636%
|
|
Reneo Pharmaceuticals, Inc.
|
-25.23 USD
|
-1136.583%
|
|
Xencor, Inc.
|
-2.08 USD
|
-14899.519%
|
|
60 Degrees Pharmaceuticals, Inc.
|
-0.95 USD
|
-32741.053%
|
|
Replimune Group, Inc.
|
-3.24 USD
|
-9529.321%
|
|
Coeptis Therapeutics Holdings, Inc.
|
-0.83 USD
|
-37489.157%
|
|
Vanda Pharmaceuticals Inc.
|
0.04 USD
|
714035.927%
|
|
Lexaria Bioscience Corp.
|
-1.01 USD
|
-30790.099%
|
|
Portage Biotech Inc.
|
-3.70 USD
|
-8332.162%
|
|
Cardio Diagnostics Holdings, Inc.
|
-0.66 USD
|
-47171.212%
|
|
Olema Pharmaceuticals, Inc.
|
-2.14 USD
|
-14478.972%
|
|
OncoCyte Corporation
|
-3.75 USD
|
-8219.733%
|
|
Qualigen Therapeutics, Inc.
|
-2.46 USD
|
-12582.52%
|
|
Processa Pharmaceuticals, Inc.
|
-8.48 USD
|
-3579.127%
|
|
Purple Biotech Ltd.
|
-0.09 USD
|
-347327.617%
|
|
CollPlant Biotechnologies Ltd.
|
-0.62 USD
|
-50220.968%
|
|
scPharmaceuticals Inc.
|
-1.42 USD
|
-21871.127%
|
|
ProMIS Neurosciences, Inc.
|
-1.42 USD
|
-21871.127%
|
|
HilleVax, Inc.
|
-3.04 USD
|
-10162.829%
|
|
NeuroSense Therapeutics Ltd.
|
-0.83 USD
|
-37489.157%
|
|
Tharimmune, Inc.
|
-107.08 USD
|
-191.362%
|
|
Genprex, Inc.
|
-22.58 USD
|
-1281.709%
|
|
Neumora Therapeutics, Inc. Common Stock
|
-1.49 USD
|
-20838.926%
|
|
Atossa Therapeutics, Inc.
|
-0.24 USD
|
-129895.833%
|
|
XTL Biopharmaceuticals Ltd.
|
-0.00 USD
|
-9454142.424%
|
|
Virios Therapeutics, Inc.
|
-0.28 USD
|
-111325.0%
|
|
OKYO Pharma Limited
|
-0.00 USD
|
-51998233.333%
|
|
Savara Inc.
|
-0.33 USD
|
-94442.424%
|
|
Curis, Inc.
|
-8.96 USD
|
-3382.031%
|
|
Daré Bioscience, Inc.
|
-4.15 USD
|
-7417.831%
|
|
Carmell Therapeutics Corporation
|
-1.46 USD
|
-21269.178%
|
|
Titan Pharmaceuticals, Inc.
|
-7.41 USD
|
-4110.391%
|
|
Achieve Life Sciences, Inc.
|
-1.50 USD
|
-20699.333%
|
|
BeiGene, Ltd.
|
-8.45 USD
|
-3592.189%
|
|
Kiromic BioPharma, Inc.
|
-21.41 USD
|
-1357.216%
|
|
Revolution Medicines, Inc. Warrant
|
-3.86 USD
|
-7982.642%
|
|
Protagonist Therapeutics, Inc.
|
-1.39 USD
|
-22345.324%
|
|
Erasca, Inc.
|
-0.83 USD
|
-37489.157%
|
|
bluebird bio, Inc.
|
-1.93 USD
|
-16065.285%
|
|
Protagenic Therapeutics, Inc.
|
-1.15 USD
|
-27029.565%
|
|
BioMarin Pharmaceutical Inc.
|
0.89 USD
|
35155.056%
|
|
DBV Technologies S.A.
|
-0.76 USD
|
-40951.316%
|
|
Protagenic Therapeutics, Inc.
|
-1.15 USD
|
-27029.565%
|
|
Moderna, Inc.
|
-12.34 USD
|
-2428.282%
|
|
Vincerx Pharma, Inc.
|
-1.89 USD
|
-16407.407%
|
|
Fresh Tracks Therapeutics, Inc.
|
-0.96 USD
|
-32398.958%
|
|
Molecular Templates, Inc.
|
-1.80 USD
|
-17232.778%
|
|
Acrivon Therapeutics, Inc. Common Stock
|
-2.74 USD
|
-11286.496%
|
|
Travere Therapeutics, Inc.
|
-1.50 USD
|
-20699.333%
|
|
Monte Rosa Therapeutics, Inc.
|
-2.63 USD
|
-11762.738%
|
|
Spruce Biosciences, Inc.
|
-1.24 USD
|
-25060.484%
|
|
Celldex Therapeutics, Inc.
|
-2.92 USD
|
-10584.589%
|
|
Cogent Biosciences, Inc.
|
-2.42 USD
|
-12792.149%
|
|
MacroGenics, Inc.
|
-0.15 USD
|
-207893.333%
|
|
RenovoRx, Inc.
|
-0.99 USD
|
-31414.141%
|
|
Adicet Bio, Inc.
|
-3.31 USD
|
-9325.68%
|
|
Prime Medicine, Inc.
|
-2.18 USD
|
-14211.468%
|
|
Aditxt, Inc.
|
-4326.64 USD
|
92.789%
|
|
Adagene Inc.
|
-0.44 USD
|
-70806.818%
|
|
Estrella Immunopharma, Inc.
|
-0.21 USD
|
-148466.667%
|
|
Quantum-Si incorporated
|
-0.68 USD
|
-45780.882%
|
|
Maravai LifeSciences Holdings, Inc.
|
-0.90 USD
|
-34565.556%
|
|
Acurx Pharmaceuticals, Inc.
|
-1.15 USD
|
-27029.565%
|
|
Voyager Therapeutics, Inc.
|
3.08 USD
|
10229.545%
|
|
SciSparc Ltd.
|
-14.43 USD
|
-2062.093%
|
|
Vericel Corporation
|
-0.07 USD
|
-466252.765%
|
|
Revelation Biosciences, Inc.
|
-0.53 USD
|
-58766.038%
|
|
Minerva Neurosciences, Inc.
|
-4.61 USD
|
-6667.679%
|
|
Generation Bio Co.
|
-1.96 USD
|
-15817.857%
|
|
Astria Therapeutics, Inc.
|
-2.42 USD
|
-12792.149%
|
|
Black Diamond Therapeutics, Inc.
|
-1.88 USD
|
-16495.213%
|
|
Arcutis Biotherapeutics, Inc.
|
-3.78 USD
|
-8153.704%
|
|
Invivyd, Inc.
|
-1.81 USD
|
-17137.017%
|
|
Relay Therapeutics, Inc.
|
-2.79 USD
|
-11082.437%
|
|
Quoin Pharmaceuticals, Ltd.
|
-9.64 USD
|
-3136.411%
|
|
Spero Therapeutics, Inc.
|
0.43 USD
|
72655.814%
|
|
Artelo Biosciences, Inc.
|
-3.49 USD
|
-8839.542%
|
|
2seventy bio, Inc.
|
-4.42 USD
|
-6958.597%
|
|
ADMA Biologics, Inc.
|
-0.13 USD
|
-239892.308%
|
|
Clene Inc.
|
-9.43 USD
|
-3208.484%
|
|
Capricor Therapeutics, Inc.
|
-0.83 USD
|
-37489.157%
|
|
Boundless Bio, Inc. Common Stock
|
-2.22 USD
|
-13953.604%
|
|
GeoVax Labs, Inc.
|
-10.22 USD
|
-2952.74%
|
|
Recursion Pharmaceuticals, Inc.
|
-1.58 USD
|
-19646.203%
|
|
Citius Pharmaceuticals, Inc.
|
-0.22 USD
|
-141713.636%
|
|
Contineum Therapeutics, Inc. Class A Common Stock
|
1.36 USD
|
23040.441%
|
|
Relmada Therapeutics, Inc.
|
-3.28 USD
|
-9411.89%
|
|
Finch Therapeutics Group, Inc.
|
-46.59 USD
|
-569.65%
|
|
ALX Oncology Holdings Inc.
|
-3.74 USD
|
-8241.979%
|
|
Vir Biotechnology, Inc.
|
-4.59 USD
|
-6697.168%
|
|
Evaxion Biotech A/S
|
-8.11 USD
|
-3746.979%
|
|
Ocular Therapeutix, Inc.
|
-1.09 USD
|
-28522.936%
|
|
Verve Therapeutics, Inc.
|
-3.12 USD
|
-9899.679%
|
|
Trevena, Inc.
|
-54.51 USD
|
-472.354%
|
|
Surrozen, Inc.
|
-21.33 USD
|
-1362.682%
|
|
Tyra Biosciences, Inc.
|
-1.62 USD
|
-19158.642%
|
|
Galmed Pharmaceuticals Ltd.
|
-30.05 USD
|
-938.236%
|
|
Unity Biotechnology, Inc.
|
-2.70 USD
|
-11455.185%
|
|
Tenax Therapeutics, Inc.
|
-31.09 USD
|
-903.506%
|
|
Terns Pharmaceuticals, Inc.
|
-1.27 USD
|
-24466.142%
|
|
ACADIA Pharmaceuticals Inc.
|
-0.37 USD
|
-84221.622%
|
|
Connect Biopharma Holdings Limited
|
-1.08 USD
|
-28787.963%
|
|
Clearmind Medicine Inc.
|
-59.18 USD
|
-427.188%
|
|
Kronos Bio, Inc.
|
-1.95 USD
|
-15899.487%
|
|
Bolt Biotherapeutics, Inc.
|
-1.83 USD
|
-16948.634%
|
|
CERo Therapeutics Holdings, Inc.
|
-0.39 USD
|
-79897.436%
|
|
Viking Therapeutics, Inc.
|
-0.91 USD
|
-34184.615%
|
|
Statera Biopharma, Inc.
|
-4.97 USD
|
-6177.465%
|
|
ImmunityBio, Inc.
|
-1.15 USD
|
-27029.565%
|
|
Korro Bio, Inc.
|
-53.08 USD
|
-487.773%
|
|
Kineta, Inc.
|
-1.28 USD
|
-24274.219%
|
|
BioVie Inc.
|
-7.30 USD
|
-4173.836%
|
|
Codexis, Inc.
|
-1.12 USD
|
-27756.25%
|
|
Celularity Inc.
|
-11.02 USD
|
-2731.125%
|
|
Crinetics Pharmaceuticals, Inc.
|
-3.69 USD
|
-8355.014%
|
|
Celcuity Inc.
|
-2.69 USD
|
-11498.141%
|
|
Virax Biolabs Group Limited
|
-3.36 USD
|
-9185.417%
|
|
Cibus, Inc.
|
-25.95 USD
|
-1102.274%
|
|
Eledon Pharmaceuticals, Inc.
|
-0.00 USD
|
-19499275.0%
|
|
eFFECTOR Therapeutics, Inc.
|
-16.37 USD
|
-1805.864%
|
|
IN8bio, Inc.
|
-1.00 USD
|
-31099.0%
|
|
Kodiak Sciences Inc.
|
-4.97 USD
|
-6177.465%
|
|
Annexon, Inc.
|
-1.77 USD
|
-17526.554%
|
|
Adverum Biotechnologies, Inc.
|
-11.62 USD
|
-2584.94%
|
|
Assembly Biosciences, Inc.
|
-13.38 USD
|
-2231.764%
|
|
Avalo Therapeutics, Inc.
|
-113.58 USD
|
-174.687%
|
|
Ionis Pharmaceuticals, Inc.
|
-2.56 USD
|
-12087.109%
|
|
Eyenovia, Inc.
|
-0.66 USD
|
-47171.212%
|
|
Puma Biotechnology, Inc.
|
0.46 USD
|
67923.913%
|
|
Conduit Pharmaceuticals Inc.
|
-0.09 USD
|
-345021.681%
|
|
Xilio Therapeutics, Inc.
|
-2.78 USD
|
-11122.662%
|
|
Arcellx, Inc.
|
-1.47 USD
|
-21123.81%
|
|
Cardiff Oncology, Inc.
|
-0.93 USD
|
-33447.312%
|
|
Enanta Pharmaceuticals, Inc.
|
-6.38 USD
|
-4790.125%
|
|
Regulus Therapeutics Inc.
|
-1.58 USD
|
-19646.203%
|
|
Moolec Science SA
|
-1.50 USD
|
-20699.333%
|
|
Acumen Pharmaceuticals, Inc.
|
-1.08 USD
|
-28787.963%
|
|
Geron Corporation
|
-0.32 USD
|
-97396.875%
|
|
LAVA Therapeutics N.V.
|
-1.57 USD
|
-19771.975%
|
|
Royalty Pharma plc
|
3.41 USD
|
9249.267%
|
|
Atea Pharmaceuticals, Inc.
|
-1.63 USD
|
-19040.491%
|
|
Greenwich LifeSciences, Inc.
|
-0.69 USD
|
-45115.942%
|
|
TFF Pharmaceuticals, Inc.
|
-11.85 USD
|
-2532.827%
|
|
Mersana Therapeutics, Inc.
|
-1.48 USD
|
-20980.405%
|
|
Humacyte, Inc.
|
-1.07 USD
|
-29057.944%
|
|
Structure Therapeutics Inc.
|
-2.44 USD
|
-12686.475%
|
|
89bio, Inc.
|
-2.00 USD
|
-15499.5%
|
|
PMV Pharmaceuticals, Inc.
|
-1.44 USD
|
-21565.972%
|
|
Avenue Therapeutics, Inc.
|
-73.60 USD
|
-323.899%
|
|
Genelux Corporation
|
-1.16 USD
|
-26795.69%
|
|
Trevi Therapeutics, Inc.
|
-0.29 USD
|
-107482.759%
|
|
Lexicon Pharmaceuticals, Inc.
|
-0.80 USD
|
-38898.75%
|
|
Notable Labs, Ltd.
|
-5.03 USD
|
-6102.584%
|
|
Liquidia Corporation
|
-1.21 USD
|
-25684.298%
|
|
Mustang Bio, Inc.
|
-6.00 USD
|
-5099.833%
|
|
Immunovant, Inc.
|
-1.88 USD
|
-16495.213%
|
|
Quantum-Si incorporated
|
-0.68 USD
|
-45780.882%
|
|
Arbutus Biopharma Corporation
|
-0.44 USD
|
-70806.818%
|
|
DiaMedica Therapeutics Inc.
|
-0.60 USD
|
-51898.333%
|
|
Vera Therapeutics, Inc.
|
-2.25 USD
|
-13766.222%
|
|
Acasti Pharma Inc.
|
-1.35 USD
|
-23010.37%
|
|
MiNK Therapeutics, Inc.
|
-0.65 USD
|
-47898.462%
|
|
Pasithea Therapeutics Corp.
|
-12.65 USD
|
-2366.324%
|
|
Xenon Pharmaceuticals Inc.
|
-2.73 USD
|
-11328.205%
|
|
Elevai Labs, Inc. Common Stock
|
-0.40 USD
|
-77897.5%
|
|
NeuroBo Pharmaceuticals, Inc.
|
-2.46 USD
|
-12582.52%
|
|
Tempest Therapeutics, Inc.
|
-1.91 USD
|
-16234.555%
|
|
Soleno Therapeutics, Inc.
|
-2.36 USD
|
-13119.915%
|
|
PepGen Inc.
|
-3.30 USD
|
-9354.242%
|
|
Moleculin Biotech, Inc.
|
-15.07 USD
|
-1970.272%
|
|
United Therapeutics Corporation
|
21.04 USD
|
1582.842%
|
|
Nuvectis Pharma, Inc.
|
-1.43 USD
|
-21717.483%
|
|
Solid Biosciences Inc.
|
-4.83 USD
|
-6359.42%
|
|
BriaCell Therapeutics Corp.
|
-0.29 USD
|
-107482.759%
|
|
Immuneering Corporation
|
-1.88 USD
|
-16495.213%
|
|
Lixte Biotechnology Holdings, Inc.
|
-2.66 USD
|
-11628.947%
|
|
Silo Pharma, Inc.
|
-1.20 USD
|
-25899.167%
|
|
Belite Bio, Inc
|
-1.19 USD
|
-26117.647%
|
|
XOMA Corporation
|
-4.04 USD
|
-7622.525%
|
|
ARS Pharmaceuticals, Inc.
|
-0.57 USD
|
-54635.088%
|
|
Bionomics Limited
|
-1.02 USD
|
-30487.255%
|
|
Apogee Therapeutics, Inc.
|
-0.00 USD
|
-9176076.471%
|
|
Alpha Tau Medical Ltd.
|
-0.42 USD
|
-74183.333%
|
|
uniQure N.V.
|
-6.47 USD
|
-4722.102%
|
|
Cassava Sciences, Inc.
|
-2.32 USD
|
-13347.845%
|
|
Estrella Immunopharma, Inc.
|
-0.21 USD
|
-148466.667%
|
|
Poseida Therapeutics, Inc.
|
-1.37 USD
|
-22672.993%
|
|
Forte Biosciences, Inc.
|
-24.92 USD
|
-1151.966%
|
|
Anebulo Pharmaceuticals, Inc.
|
-0.32 USD
|
-97396.875%
|
|
Enlivex Therapeutics Ltd.
|
-1.56 USD
|
-19899.359%
|
|
Conduit Pharmaceuticals Inc.
|
-0.09 USD
|
-345021.681%
|
|
SeaStar Medical Holding Corporation
|
-30.29 USD
|
-930.01%
|
|
FibroBiologics, Inc. Common Stock
|
-0.59 USD
|
-52779.661%
|
|
Altimmune, Inc.
|
-1.66 USD
|
-18694.578%
|
|
Amicus Therapeutics, Inc.
|
-0.51 USD
|
-61074.51%
|
|
Alpha Tau Medical Ltd.
|
-0.42 USD
|
-74183.333%
|
|
Compugen Ltd.
|
-0.21 USD
|
-148466.667%
|
|
Peak Bio, Inc.
|
- USD
|
Infinity%
|
|
Zevra Therapeutics, Inc.
|
-1.30 USD
|
-23899.231%
|
|
Benitec Biopharma Inc.
|
-5.36 USD
|
-5720.709%
|
|
Spyre Therapeutics, Inc.
|
-49.12 USD
|
-535.159%
|
|
NKGen Biotech, Inc. Common Stock
|
-5.38 USD
|
-5699.071%
|
|
Zura Bio Limited
|
-2.09 USD
|
-14827.751%
|
|
PolyPid Ltd.
|
-16.99 USD
|
-1736.315%
|
|
Aileron Therapeutics, Inc.
|
-3.42 USD
|
-9022.515%
|
|
NKGen Biotech, Inc. Warrants
|
-5.38 USD
|
-5699.071%
|
|
Instil Bio, Inc.
|
-24.00 USD
|
-1199.958%
|
|
argenx SE
|
-5.16 USD
|
-5946.318%
|
|
Immunome, Inc.
|
-5.38 USD
|
-5699.071%
|
|
Compass Therapeutics, Inc.
|
-0.33 USD
|
-94442.424%
|
|
Verona Pharma plc
|
-0.54 USD
|
-57675.926%
|
|
enGene Holdings Inc. Warrants
|
-4.51 USD
|
-6817.738%
|
|
Shattuck Labs, Inc.
|
-2.05 USD
|
-15119.024%
|
|
CervoMed Inc.
|
-0.82 USD
|
-37947.561%
|
|
LENZ Therapeutics, Inc.
|
-15.30 USD
|
-1939.15%
|
|
Plus Therapeutics, Inc.
|
-4.24 USD
|
-7258.255%
|
|
Dianthus Therapeutics, Inc.
|
-8.45 USD
|
-3592.189%
|
|
Moolec Science SA
|
-1.50 USD
|
-20699.333%
|
|
Enveric Biosciences, Inc.
|
-8.09 USD
|
-3756.489%
|
|
Inovio Pharmaceuticals, Inc.
|
-6.09 USD
|
-5022.989%
|
|
AnaptysBio, Inc.
|
-6.08 USD
|
-5031.414%
|
|
Design Therapeutics, Inc.
|
-1.19 USD
|
-26117.647%
|
|
Leap Therapeutics, Inc.
|
-3.98 USD
|
-7738.945%
|
|
NeurAxis, Inc.
|
-4.03 USD
|
-7641.687%
|
|
Seelos Therapeutics, Inc.
|
-7.73 USD
|
-3936.093%
|
|
Lumos Pharma, Inc.
|
-4.18 USD
|
-7363.876%
|
|
Achilles Therapeutics plc
|
-1.74 USD
|
-17830.46%
|
|
enGene Holdings Inc. Common Stock
|
-4.51 USD
|
-6817.738%
|
|
180 Life Sciences Corp.
|
-52.60 USD
|
-493.137%
|
|
Opiant Pharmaceuticals, Inc.
|
0.68 USD
|
45980.882%
|
|
CERo Therapeutics Holdings, Inc.
|
-0.39 USD
|
-79897.436%
|
|
Nutriband Inc.
|
-0.69 USD
|
-45115.942%
|
|
ORIC Pharmaceuticals, Inc.
|
-1.96 USD
|
-15817.857%
|
|
CG Oncology, Inc. Common stock
|
-15.65 USD
|
-1893.546%
|
|
Fractyl Health, Inc. Common Stock
|
-1.98 USD
|
-15657.071%
|
|
Rani Therapeutics Holdings, Inc.
|
-1.33 USD
|
-23357.895%
|
|
MoonLake Immunotherapeutics
|
-0.73 USD
|
-42638.356%
|
|
Palisade Bio, Inc.
|
-27.01 USD
|
-1055.091%
|
|
Tourmaline Bio, Inc.
|
-8.87 USD
|
-3417.362%
|
|
Beam Therapeutics Inc.
|
-1.72 USD
|
-18038.953%
|
|
Neurogene Inc.
|
-2.83 USD
|
-10924.382%
|
|
Mirum Pharmaceuticals, Inc.
|
-4.00 USD
|
-7699.75%
|
|
AEON Biopharma, Inc.
|
- USD
|
Infinity%
|
|
CARGO Therapeutics, Inc. Common Stock
|
-2.38 USD
|
-13008.824%
|
|
Sesen Bio, Inc.
|
-1.99 USD
|
-15577.889%
|
|
Enliven Therapeutics, Inc.
|
-2.01 USD
|
-15421.891%
|
|
Kiora Pharmaceuticals, Inc.
|
-24.25 USD
|
-1186.557%
|
|
Iovance Biotherapeutics, Inc.
|
-1.89 USD
|
-16407.407%
|
|
Taysha Gene Therapies, Inc.
|
-0.96 USD
|
-32398.958%
|
|
Athira Pharma, Inc.
|
-3.10 USD
|
-9964.194%
|
|
Vaccinex, Inc.
|
-43.68 USD
|
-614.263%
|
|
HCW Biologics Inc.
|
-0.70 USD
|
-44470.0%
|
|
XOMA Corporation
|
-4.04 USD
|
-7622.525%
|
|
Nektar Therapeutics
|
-1.45 USD
|
-21416.552%
|
|
Arvinas, Inc.
|
-6.62 USD
|
-4612.84%
|
|
Tevogen Bio Holdings Inc.
|
-0.00 USD
|
-77997400.0%
|
|
Merus N.V.
|
-3.00 USD
|
-10299.667%
|
|
Omega Therapeutics, Inc.
|
-1.80 USD
|
-17232.778%
|
|
Quince Therapeutics, Inc.
|
-0.84 USD
|
-37041.667%
|
|
Rezolute, Inc.
|
-1.33 USD
|
-23357.895%
|
|
Clene Inc.
|
-9.43 USD
|
-3208.484%
|
|
Indaptus Therapeutics, Inc.
|
-1.84 USD
|
-16855.978%
|
|
BeyondSpring Inc.
|
-0.54 USD
|
-57675.926%
|
|
Synlogic, Inc.
|
-8.81 USD
|
-3441.317%
|
|
Allarity Therapeutics, Inc.
|
-0.01 USD
|
-3028929.126%
|
|
Phio Pharmaceuticals Corp.
|
-46.87 USD
|
-565.65%
|
|
Peak Bio, Inc.
|
- USD
|
Infinity%
|
|
Werewolf Therapeutics, Inc.
|
-1.05 USD
|
-29613.333%
|
|
Krystal Biotech, Inc.
|
0.40 USD
|
78097.5%
|
|
Karyopharm Therapeutics Inc.
|
-1.25 USD
|
-24859.2%
|
|
SpringWorks Therapeutics, Inc.
|
-5.15 USD
|
-5958.058%
|
|
Lipella Pharmaceuticals Inc.
|
-0.77 USD
|
-40418.182%
|
|
MannKind Corporation
|
-0.04 USD
|
-697864.206%
|
|
Ikena Oncology, Inc.
|
-1.63 USD
|
-19040.491%
|
|
Cyclerion Therapeutics, Inc.
|
-8.99 USD
|
-3370.412%
|
|
Gyre Therapeutics, Inc.
|
-1.41 USD
|
-22026.95%
|
|
Gossamer Bio, Inc.
|
-1.18 USD
|
-26339.831%
|
|
CohBar, Inc.
|
-4.13 USD
|
-7454.237%
|
|
Cognition Therapeutics, Inc.
|
-0.86 USD
|
-36177.907%
|
|
NRx Pharmaceuticals, Inc.
|
-3.98 USD
|
-7738.945%
|
|
Legend Biotech Corporation
|
-2.94 USD
|
-10511.905%
|
|
Mural Oncology plc
|
-12.43 USD
|
-2409.976%
|
|
Biora Therapeutics, Inc.
|
-7.87 USD
|
-3864.295%
|
|
PaxMedica, Inc. Common Stock
|
-11.00 USD
|
-2736.273%
|
|
Disc Medicine, Inc.
|
-3.43 USD
|
-8995.918%
|
|
Champions Oncology, Inc.
|
-0.54 USD
|
-57675.926%
|
|
REGENXBIO Inc.
|
-6.02 USD
|
-5082.558%
|
|
Ensysce Biosciences, Inc.
|
-4.69 USD
|
-6552.239%
|
|
Anavex Life Sciences Corp.
|
-0.60 USD
|
-51898.333%
|
|
Cellectar Biosciences, Inc.
|
-3.11 USD
|
-9931.833%
|
|
Edgewise Therapeutics, Inc.
|
-1.57 USD
|
-19771.975%
|
|
Vaxart, Inc.
|
-0.57 USD
|
-54635.088%
|
|
PharmaCyte Biotech, Inc.
|
-1.80 USD
|
-17232.778%
|
|
Aldeyra Therapeutics, Inc.
|
-0.64 USD
|
-48648.438%
|
|
Cellectis S.A.
|
-1.77 USD
|
-17526.554%
|
|
Longeveron Inc.
|
-10.22 USD
|
-2952.74%
|
|
Repare Therapeutics Inc.
|
-2.23 USD
|
-13890.583%
|
|
Sarepta Therapeutics, Inc.
|
-5.80 USD
|
-5279.138%
|
|
Inozyme Pharma, Inc.
|
-1.37 USD
|
-22672.993%
|
|
Revolution Medicines, Inc.
|
-3.86 USD
|
-7982.642%
|
|
Nymox Pharmaceutical Corporation
|
-0.07 USD
|
-424376.19%
|
|
Third Harmonic Bio, Inc.
|
-0.78 USD
|
-39898.718%
|
|
ArriVent BioPharma, Inc. Common Stock
|
-2.17 USD
|
-14277.419%
|
|
AN2 Therapeutics, Inc.
|
-2.74 USD
|
-11286.496%
|
|
Anixa Biosciences, Inc.
|
-0.32 USD
|
-97396.875%
|
|
Vertex Pharmaceuticals Incorporated
|
14.05 USD
|
2320.569%
|
|
Denali Therapeutics Inc.
|
-1.06 USD
|
-29333.019%
|
|
Revelation Biosciences, Inc.
|
-0.53 USD
|
-58766.038%
|
|
Veru Inc.
|
-1.10 USD
|
-28262.727%
|
|
Corvus Pharmaceuticals, Inc.
|
-0.56 USD
|
-55612.5%
|
|
Cingulate Inc.
|
-311.99 USD
|
-0.0%
|
|
Passage Bio, Inc.
|
-1.86 USD
|
-16673.656%
|
|
Context Therapeutics Inc.
|
-1.50 USD
|
-20699.333%
|
|
Exicure, Inc.
|
-2.11 USD
|
-14686.256%
|
|
Day One Biopharmaceuticals, Inc.
|
-2.37 USD
|
-13064.135%
|
|
Oramed Pharmaceuticals Inc.
|
-0.97 USD
|
-32063.918%
|
|
Scinai Immunotherapeutics Ltd.
|
-16.62 USD
|
-1777.196%
|
|
Rhythm Pharmaceuticals, Inc.
|
-3.20 USD
|
-9649.688%
|
|
Nuvalent, Inc.
|
-2.17 USD
|
-14277.419%
|
|
ABVC BioPharma, Inc.
|
-2.43 USD
|
-12739.095%
|
|
Carisma Therapeutics, Inc.
|
-2.59 USD
|
-11945.946%
|
|
Unicycive Therapeutics, Inc.
|
-1.28 USD
|
-24274.219%
|
|
OmniAb, Inc.
|
-0.51 USD
|
-61074.51%
|
|
Anew Medical, Inc.
|
0.14 USD
|
222950.0%
|
|
Fennec Pharmaceuticals Inc.
|
-0.60 USD
|
-51898.333%
|
|
Lipocine Inc.
|
-3.14 USD
|
-9835.987%
|
|
Lexeo Therapeutics, Inc. Common Stock
|
-2.49 USD
|
-12429.719%
|
|
Nautilus Biotechnology, Inc.
|
-0.51 USD
|
-61074.51%
|
|
SAB Biotherapeutics, Inc.
|
-7.64 USD
|
-3983.639%
|
|
G1 Therapeutics, Inc.
|
-0.93 USD
|
-33447.312%
|
|
Bellerophon Therapeutics, Inc.
|
-2.08 USD
|
-14899.519%
|
|
Sage Therapeutics, Inc.
|
-9.05 USD
|
-3347.403%
|
|
Ocugen, Inc.
|
-0.26 USD
|
-119896.154%
|
|
Mind Medicine (MindMed) Inc.
|
-2.44 USD
|
-12686.475%
|
|
Q32 Bio Inc.
|
-35.16 USD
|
-787.344%
|
|
Brainstorm Cell Therapeutics Inc.
|
-0.40 USD
|
-77897.5%
|
|
Alumis Inc. Common Stock
|
-2.99 USD
|
-10334.448%
|
|
Equillium, Inc.
|
-0.38 USD
|
-82002.632%
|
|
Kyverna Therapeutics, Inc.
|
-0.00 USD
|
-311989900.0%
|
|
Coya Therapeutics, Inc.
|
-0.79 USD
|
-39392.405%
|
|
CNS Pharmaceuticals, Inc.
|
-251.35 USD
|
-24.126%
|
|
Galera Therapeutics, Inc.
|
-1.33 USD
|
-23357.895%
|
|
Evelo Biosciences, Inc.
|
-26.28 USD
|
-1087.177%
|
|
Comera Life Sciences Holdings, Inc.
|
-1.76 USD
|
-17626.705%
|
|
Dominari Holdings Inc.
|
-4.38 USD
|
-7023.059%
|
|
Edesa Biotech, Inc.
|
-2.93 USD
|
-10548.123%
|
|
vTv Therapeutics Inc.
|
-9.71 USD
|
-3113.079%
|
|
Bio-Techne Corporation
|
1.07 USD
|
29257.944%
|
|
Agios Pharmaceuticals, Inc.
|
-6.33 USD
|
-4828.752%
|
|
Harmony Biosciences Holdings, Inc.
|
2.17 USD
|
14477.419%
|
|
Prelude Therapeutics Incorporated
|
-2.02 USD
|
-15345.05%
|
|
Candel Therapeutics, Inc.
|
-1.31 USD
|
-23716.031%
|
|
iTeos Therapeutics, Inc.
|
-3.15 USD
|
-9804.444%
|
|
Nkarta, Inc.
|
-2.40 USD
|
-12899.583%
|
|
BioCardia, Inc.
|
-8.19 USD
|
-3709.402%
|
|
Iterum Therapeutics plc
|
-2.96 USD
|
-10440.203%
|
